{"id":"https://openalex.org/W2003222087","doi":"https://doi.org/10.2174/0929867033456855","title":"Human Cytochromes P450 Associated with the Phase 1 Metabolism of Drugs and other Xenobiotics: A Compilation of Substrates and Inhibitors of the CYP1, CYP2 and CYP3 Families","display_name":"Human Cytochromes P450 Associated with the Phase 1 Metabolism of Drugs and other Xenobiotics: A Compilation of Substrates and Inhibitors of the CYP1, CYP2 and CYP3 Families","publication_year":2003,"publication_date":"2003-10-01","ids":{"openalex":"https://openalex.org/W2003222087","doi":"https://doi.org/10.2174/0929867033456855","mag":"2003222087","pmid":"https://pubmed.ncbi.nlm.nih.gov/12871098"},"language":"en","primary_location":{"id":"doi:10.2174/0929867033456855","doi":"https://doi.org/10.2174/0929867033456855","is_oa":false,"landing_page_url":"https://doi.org/10.2174/0929867033456855","pdf_url":null,"source":{"id":"https://openalex.org/S33159018","display_name":"Current Medicinal Chemistry","issn_l":"0929-8673","issn":["0929-8673","1875-533X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111713300","display_name":"David F. V. Lewis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28290843","display_name":"University of Surrey","ror":"https://ror.org/00ks66431","country_code":"GB","type":"education","lineage":["https://openalex.org/I28290843"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"David Lewis","raw_affiliation_strings":["School of Biomedical and Life Sciences, University of Surrey, Guildford, Surrey, GU2 7XH, UK. d.lewis@surrey.ac.uk","School of Biomedical and Life Sciences, University of Surrey, Guildford, Surrey, GU2 7XH, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Biomedical and Life Sciences, University of Surrey, Guildford, Surrey, GU2 7XH, UK. d.lewis@surrey.ac.uk","institution_ids":["https://openalex.org/I28290843"]},{"raw_affiliation_string":"School of Biomedical and Life Sciences, University of Surrey, Guildford, Surrey, GU2 7XH, UK","institution_ids":["https://openalex.org/I28290843"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5111713300"],"corresponding_institution_ids":["https://openalex.org/I28290843"],"apc_list":null,"apc_paid":null,"fwci":3.4291,"has_fulltext":false,"cited_by_count":132,"citation_normalized_percentile":{"value":0.92599882,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"10","issue":"19","first_page":"1955","last_page":"1972"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11747","display_name":"Metal-Catalyzed Oxygenation Mechanisms","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1604","display_name":"Inorganic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cytochrome-p450","display_name":"cytochrome P450","score":0.9480000138282776},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.8019999861717224},{"id":"https://openalex.org/keywords/xenobiotics","display_name":"xenobiotics","score":0.746999979019165},{"id":"https://openalex.org/keywords/enzyme-substrates","display_name":"enzyme substrates","score":0.8830000162124634},{"id":"https://openalex.org/keywords/enzyme-inhibitors","display_name":"enzyme inhibitors","score":0.9900000095367432},{"id":"https://openalex.org/keywords/michaelis-constant","display_name":"Michaelis constant","score":0.7480000257492065},{"id":"https://openalex.org/keywords/inhibition-constant","display_name":"inhibition constant","score":0.8309999704360962},{"id":"https://openalex.org/keywords/lipophilicity","display_name":"lipophilicity","score":0.9459999799728394},{"id":"https://openalex.org/keywords/pka","display_name":"pKa","score":0.8510000109672546},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.925000011920929},{"id":"https://openalex.org/keywords/enzyme-active-site","display_name":"enzyme active site","score":0.5920000076293945}],"concepts":[{"id":"https://openalex.org/C201399114","wikidata":"https://www.wikidata.org/wiki/Q898401","display_name":"Lipophilicity","level":2,"score":0.7752343416213989},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.7640321850776672},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.7018908858299255},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.5986499786376953},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.5687536001205444},{"id":"https://openalex.org/C119795356","wikidata":"https://www.wikidata.org/wiki/Q407801","display_name":"Isozyme","level":3,"score":0.5601640939712524},{"id":"https://openalex.org/C89311334","wikidata":"https://www.wikidata.org/wiki/Q1124842","display_name":"Drug metabolism","level":3,"score":0.4880041182041168},{"id":"https://openalex.org/C115448650","wikidata":"https://www.wikidata.org/wiki/Q409205","display_name":"Xenobiotic","level":3,"score":0.4843660295009613},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4743850529193878},{"id":"https://openalex.org/C2777289219","wikidata":"https://www.wikidata.org/wiki/Q7632154","display_name":"Substrate (aquarium)","level":2,"score":0.45370030403137207},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4527743458747864},{"id":"https://openalex.org/C2778307567","wikidata":"https://www.wikidata.org/wiki/Q3860934","display_name":"Unspecific monooxygenase","level":5,"score":0.4451879560947418},{"id":"https://openalex.org/C2994592520","wikidata":"https://www.wikidata.org/wiki/Q5090496","display_name":"Substrate specificity","level":3,"score":0.44039595127105713},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.37262046337127686},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3378834128379822},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.16399267315864563},{"id":"https://openalex.org/C86745063","wikidata":"https://www.wikidata.org/wiki/Q3737406","display_name":"CYP1A2","level":4,"score":0.09363847970962524},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006860","descriptor_name":"Hydrogen Bonding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013379","descriptor_name":"Substrate Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015262","descriptor_name":"Xenobiotics","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065607","descriptor_name":"Cytochrome P-450 Enzyme Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.2174/0929867033456855","doi":"https://doi.org/10.2174/0929867033456855","is_oa":false,"landing_page_url":"https://doi.org/10.2174/0929867033456855","pdf_url":null,"source":{"id":"https://openalex.org/S33159018","display_name":"Current Medicinal Chemistry","issn_l":"0929-8673","issn":["0929-8673","1875-533X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:12871098","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12871098","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2063442560","https://openalex.org/W2032956776","https://openalex.org/W2161471267","https://openalex.org/W2062812784","https://openalex.org/W2113984935","https://openalex.org/W1549015103","https://openalex.org/W2082907683","https://openalex.org/W2162981425","https://openalex.org/W2011689559","https://openalex.org/W2106109834"],"abstract_inverted_index":{"This":[0],"review":[1],"represents":[2],"a":[3,73],"compilation":[4,132],"of":[5,57,76,119],"typical":[6],"substrates":[7,35,108],"and":[8,28,36,41,45,61,65,121],"inhibitors":[9,37,87],"for":[10,72,109],"human":[11,142],"cytochrome":[12],"P450":[13],"(CYP)":[14],"enzymes":[15],"that":[16,102],"are":[17,49,69,104],"involved":[18],"in":[19,54,135],"drug":[20],"metabolism,":[21],"specifically":[22],"those":[23],"from":[24],"the":[25,42,55,92,110,125],"CYP1,":[26],"CYP2":[27],"CYP3":[29],"families.":[30],"Relatively":[31],"recent":[32],"literature":[33],"on":[34,82,96],"has":[38],"been":[39,89],"collected":[40],"relevant":[43,126],"K(m)":[44],"K(i)":[46],"values,":[47],"respectively,":[48],"tabulated.":[50],"Furthermore,":[51],"physicochemical":[52],"properties":[53],"form":[56],"lipophilicity":[58],"(log":[59],"P":[60],"log":[62],"D(7.4)":[63],"values)":[64,68],"acidity/basicity":[66],"(pK(a)":[67],"also":[70],"tabulated":[71],"significant":[74],"number":[75],"substrates,":[77],"together":[78],"with":[79,114,124],"some":[80],"information":[81,100],"inhibitors,":[83],"although":[84],"only":[85],"key":[86],"have":[88],"selected":[90],"as":[91],"main":[93],"focus":[94],"is":[95],"substrates.":[97],"The":[98,131],"collated":[99],"indicates":[101],"there":[103],"certain":[105],"commonalities":[106],"between":[107],"same":[111],"enzyme,":[112],"especially":[113],"respect":[115],"to":[116],"their":[117],"positions":[118],"metabolism":[120],"likely":[122],"interactions":[123],"enzyme":[127],"active":[128],"site":[129],"regions.":[130],"therefore":[133],"assists":[134],"establishing":[136],"substrate":[137],"structure-activity":[138],"relationships":[139],"(SSARs)":[140],"within":[141],"drug-metabolizing":[143],"P450s.":[144]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}